Skip to main content

Your DNA Could Be the Next Target

Your DNA Could Be the Next Target: Scientists Warn of Looming Cyber Threats to Genetic Data


As the digital revolution transforms modern medicine, a less visible but equally powerful frontier is emerging—one that involves code of a different kind: DNA. The same sequences used to fight cancer, personalize treatment, and trace ancestry are now the focus of a growing cyber threat.

A recent study conducted by Dr. Anjum and his team at the University of Portsmouth has issued a stark warning: cybercriminals could potentially target and exploit DNA data, particularly through the vulnerabilities of widely adopted Next-Generation Sequencing (NGS) platforms.
ALSO READ: Call for Cyber Experts: Join FCRF Academy as Trainers and Course Creators

These platforms digitize genetic samples and transfer them to cloud-based systems for analysis—a practice that, while revolutionizing biotechnology, has exposed the field to the risks familiar in other domains of cybersecurity. The threat isn’t just theoretical. With the help of artificial intelligence, bad actors could manipulate DNA data for blackmail, identity tracing, or even weaponize synthetic biology.
The Unseen Cyber-Biosecurity Crisis

While conventional cybersecurity systems focus on emails, servers, or bank accounts, scientists are now sounding the alarm about cyber-biosecurity—a lesser-known discipline that deals with protecting the vast databases of genetic material.

“Protecting genomic data isn’t just about encryption—it’s about anticipating attacks that don’t yet exist,” said Dr. Anjum. His research emphasized the emerging threat of synthetic biology attacks, where malicious actors could alter or inject rogue DNA sequences into legitimate workflows.

The risks are manifold: hacked genetic databases could lead to identity theft on a cellular level, unauthorized DNA modification, or even forged genetic identities. Dr. Anjum’s team proposes that institutions must move beyond basic data protection and begin monitoring workflows for irregular behavior, using AI to predict and block anomalous activities.
Why Hackers Want Your Genes

Genomic data is more than just medical—it is identity. That makes it a high-value target. Experts point out that with the rise in precision medicine and global genetic databases, hackers have a financial and ideological incentive to infiltrate gene banks. They could demand ransom in return for deleting stolen data, create fraudulent health profiles, or reverse-engineer medical research.

Moreover, certain tools such as Bytespider—an AI web crawler allegedly linked to ByteDance—have shown how even benign technologies could be repurposed to collect or misuse genomic datasets.

Cybersecurity experts are calling for a multidisciplinary response: bringing together geneticists, data scientists, and infosec professionals to create a digital perimeter around biology’s most sensitive frontier. Initiatives may include mandatory data anonymization, digital watermarking of DNA sequences, and constant real-time monitoring for tampering.

DNA sequencing, genetic code, nucleotides, double helix, genome, base pairs, replication, transcription, translation, genetic mutation, CRISPR, molecular biology, gene expression, heredity, DNA polymerase, RNA, genetic engineering, DNA fingerprinting, epigenetics, biotechnology

#DNA, #Genetics, #MolecularBiology, #Genome, #CRISPR, #GeneEditing, #Biotech, #Genomics, #DNASequencing, #DNAResearch, #GeneticEngineering, #RNA, #Heredity, #Epigenetics, #GeneTherapy, #Bioinformatics, #DoubleHelix, #Nucleotides, #DNATechnology, #DNAScience

International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Award registration: genetics-conferences.healthcarek.com/award-registration/

For Enquiries: contact@healthcarek.com

Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
youtube.com/@GeneticsHealthcare

Comments

Post a Comment

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...
Post a Comment
Read more

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...
Post a Comment
Read more